INSIGHT photo 0 INSIGHT photo 1 INSIGHT photo 2 INSIGHT photo 3

Abstracts & Presentations

International Conferences

2006 International Conferences

(By conference, by month, by author)

10th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI), Bethesda, Maryland, October 2006

Abrams D, Risk of cancers during interrupted antiretroviral therapy: malignant outcomes in the SMART study -- Abstract | Poster | Slides

XVI International AIDS Conference, Toronto, Canada, August 2006

Burman W, The effect of episodic CD4-guided antiretroviral therapy on quality of life: Results of the quality of life substudy of SMART -- Abstract | Slides

Cohn D, Severity and types of clinical events by proximal CD4 cell counts in the SMART study -- Abstract | Poster

El-Sadr W, Inferior clinical outcomes with episodic CD4-guided antiretroviral therapy aimed at drug conservation (DC) in SMART study: Consistency of finding in all patient subgroups -- Abstract | Slides

Grund B, Predictors for the initial CD4 decline after antiretroviral treatment interruption in the SMART study -- Abstract | Poster

Lundgren JD, Progression of HIV-related disease or death (POD) in the randomized SMART study: Why was the risk of POD greater in the CD4-guided ((re)-initiate ART at CD4 < 250 cells/μL) drug conservation (DC) vs the virological suppression (VS) arm? -- Abstract | Slides

13th CROI, Denver, Colorado, February 2006

Carr A, ART and asymptomatic ischemic heart disease in HIV-infected adults: A cross-sectional analysis of patients enrolling in the SMART trial -- Abstract | Poster

El-Sadr W, Episodic CD4-guided used of antiretroviral therapy is inferior to continuous therapy: Results of the SMART study -- Abstract | Slides

INSIGHT Footer
Email Webmaster with questions or suggestions.